Here we show for the first time that the AR is a direct positive regulator of RUNX1 gene expression in AR+-TNBC and that RUNX1 transcriptional activity is involved in the CSC-like phenotype and chemoresistance, contributing to tumor progression in this aggressive breast cancer subtype. Here, RUNX1 is linked to breast cancer.